Psilocybin for Pain and TBI

References:Structural comparison of DMT, psilocin, and serotonin. Adkins A and Ferguson MC. “Research update: MDMA and psilocybin for pain management.” Practical Pain Management. 18 June 2022. https://www.practicalpainmanagement.com/news/research-update-mdma-and-psilocybin-for-pain-management. Accessed 30 July 2023Bornemann J, et al. “Self-medication for chronic pain using class psychedelics: A qualitative investigation to inform future research.” Frontiers in Psychiatry. 18 June 2022. https://www.practicalpainmanagement.com/news/research-update-mdma-and-psilocybin-for-pain-management Accessed 31 July 2023. Fanciullacci M, et al. “Brief report: phantom limb pain: sub-hallucinogenic treatment with lysergic acid diethylamide (LSD).” Headache. 1977 July; 17(3): 118-119. https://pubmed.ncbi.nlm.nih.gov/893080/ Accessed 30 July 2023Flanagan T, Nichols C. “Psychedelics as anti-inflammatory agents.” Psychedelic Research. 13 Aug 2018. Accessed 28 July 2023. https://blossomanalysis.com/papers/psychedelics-as-anti-inflammatory-agents/Hawryluk M. “Pain, hope, and science collide as athletes turn to magic mushrooms.” WUSF Public Media. 30 Apr 2023. https://wusfnews.wusf.usf.edu/health-news-florida/2023-04-30/pain-hope-and-science-collide-as-athletes-turn-to-magic-mushrooms Accessed 30 July 2023. Kooijman NI, et al. “Are psychedelics the answer to chronic pain: A review of current literature.” Pain Pract. 2023 Apr;23(4):447-458. Accessed 30 July 2023. doi: 10.1111/papr.13203. Epub 2023 Jan 11. PMID: 36597700.“Lobe Sciences announces launch of pre-clinical study in collaboration with the University of Miami Miller School of Medicine.” Newsfile. 30 Nov 2020. Accessed 27 July 2023. https://www.newsfilecorp.com/release/69106/Lobe-Sciences-Announces-Launch-of-Preclinical-Study-in-Collaboration-with-the-University-of-Miami-Miller-School-of-MedicineMade, Rachel. “Jim Harris was paralyzed. Then he ate magic mushrooms.” Outside. 9 Nov 2022. Accessed 27 July 2023. https://www.outsideonline.com/outdoor-adventure/exploration-survival/psychedelics-research-paralysis-treatment-jim-harris/Mansoor Khan S, et al. “Psychedelics for brain injury: a mini review.” Frontiers in Neurology. 2021(12). 29 July 2021. Accessed 28 July 2023. https://www.frontiersin.org/articles/10.3389/fneur.2021.685085/fullPrice S. “Data shows combination psilocybin therapy effective for TBI and PTSD.” Psychedelic Health UK. 30 Sept 2021. Accessed 30 July 2023. https://psychedelichealth.co.uk/2021/09/30/data-shows-combination-psilocybin-therapy-effective-for-tbi-and-ptsd/Rauchman B. “UFC fighter’s brain injury successfully treated with psychedelic therapy.” Pacific Neuroscience Institute. 6 July 2023. Accessed 28 July 2023. https://www.pacificneuroscienceinstitute.org/blog/trip/ufc-fighters-brain-injury-successfully-treated-with-psychedelic-therapy/Ramachandran V, et al. “Relief from intractable phantom pain by combining psilocybin and mirror visual feedback (MVF).” Neurocase. 2018 Apr; 24(2): 105-110. Accessed 29 July 2023. https://pubmed.ncbi.nlm.nih.gov/29764303/Rosenhall U, et al. “Treatment of military acoustic accidents with n-acetyl-l-cysteine (NAC). Int J Audiology. 2019 March; 58(3): 151-157. Accessed 30 July 2023. https://pubmed.ncbi.nlm.nih.gov/30653365/Schindler et al. “Exploratory investigation of a patient informed low dose psilocybin pulse regimen in the suppression of cluster headaches: results from a randomized, double-blind, placebo-controlled trial.” Headache. 23 Nov 2022. https://headachejournal.onlinelibrary.wiley.com/doi/abs/10.1111/head.14420 Accessed 30 July 2023. “Traumatic Brain Injury and Concussion.” Centers for Disease Control. Last Reviewed: 7 July 2023. Last access 29 July 2023. https://www.cdc.gov/traumaticbraininjury/data/index.html Get full access to Neural Pharm at neuralpharm.substack.com/subscribe